HAMBURG, Germany & TOKYO—In mid-march, Eppendorf AG and Koki Holdings Co. Ltd. reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. The acquisition marks a targeted step by German company Eppendorf AG to expand its centrifuge business, and it says that the deal “solidifies its strong market position as one of the world’s leading makers of high-end centrifuges for the pharma and life-science industries, as well as academic and commercial research.” 
“We are excited to acquire Koki’s centrifuge business and its premium himac brand. These high-performance products are an ideal fit for Eppendorf’s centrifuges business and high-quality standards,” stated Dr. Peter Fruhstorfer, co-CEO of Eppendorf AG. “With this acquisition, Eppendorf will become a full-line provider of high-performance premium centrifuges on a global level. This gives us access to new customer groups and offers opportunities for further growth.”
Continue reading below...
WebinarsAccelerating rare disease clinical trials
Explore how a rare kidney disease trial achieved faster patient enrollment with data-informed strategies and collaborative partnerships.
Read MoreThe centrifuge business is one of Eppendorf’s core businesses, Fruhstorfer continued, which will be sustainably strengthened by the acquisition.
“We are excited to have Eppendorf as a partner in acquiring our Centrifuge & Processing (C&P) business, which has held a first-place business track record in Japan for over 65 years,” said Atsushi Morisawa, CEO of Koki Holdings. “With Eppendorf’s investment through this acquisition, I am sure the Koki-originated C&P business will earn an extraordinary positioning in the global market. With that, Koki Holdings will strategically focus on the power tool industry to become the top brand globally.”
